Research Article
Growing Menace of Antibacterial Resistance in Clinical Isolates of Pseudomonas aeruginosa in Nepal: An Insight of Beta-Lactamase Production
Table 2
Antibacterial resistance rates of Pseudomonas aeruginosa isolates.
| | Antibiotics | Pus (32)
Number (%) | Sputum (68)
Number (%) | Urine (42)
Number (%) | Blood (20)
Number (%) | ET-tube (8)
Number (%) | Swab (4)
Number (%) | BAL (2)
Number (%) | Pleural fluid (2)
Number (%) | Total (178)
Number (%) |
| | CAZ | 24 (75) | 56 (82.3) | 30 (71.4) | 9 (45.0) | 6 (75.0) | 3 (75.0) | 2 (100) | 0 | 130 (73.0) | | CTR | 12 (37.5) | 30 (44.1) | 26 (61.9) | 12 (60.0) | 6 (75.0) | 4 (100) | 2 (100) | 0 | 92 (51.7) | | CTX | 24 (75) | 26 (38.2) | 34 (80.9) | 8 (40.0) | 6 (75.0) | 4 (100) | 0 | 0 | 102 (57.3) | | CFM | 16 (50) | 59 (86.8) | 32 (76.2) | 16 (80.0) | 8 (100) | 3 (75.0) | 0 | 2 (100) | 134 (75.3) | | IPM | 12 (37.5) | 28 (41.2) | 18 (42.8) | 4 (20.0) | 8 (100) | 1 (25.0) | 0 | 0 | 71 (40.0) | | MRP | 12 (37.5) | 28 (41.2) | 16 (38.1) | 6 (30.0) | 8 (100) | 1 (25.0) | 0 | 0 | 71 (40.0) | | CB | 12 (37.5) | 18 (26.5) | 26 (61.9) | 4 (20.0) | 4 (50.0) | 2 (50.0) | 2 (100) | 0 | 68 (38.2) | | PI | 24 (75) | 55 (80.9) | 32 (76.2) | 13 (65.0) | 8 (100) | 4 (100) | 2 (100) | 2 (100) | 140 (78.6) | | PIT | 16 (50) | 21 (30.9) | 16 (38.1) | 6 (30.0) | 5 (62.5) | 2 (50.0) | 1 (50.0) | 2 (100) | 69 (38.8) | | CIP | 8 (25) | 30 (44.1) | 36 (85.7) | 11 (55.0) | 6 (75.0) | 0 | 0 | 0 | 91 (51.1) | | GEN | 12 (37.5) | 8 (11.8) | 14 (33.3) | 8 (40.0) | 6 (75.0) | 2 (50.0) | 0 | 0 | 50 (28.1) | | AK | 6 (18.75) | 6 (8.8) | 12 (28.6) | 4 (20.0) | 0 | 0 | 0 | 0 | 28 (15.7) | | TOB | 6 (18.75) | 8 (11.8) | 8 (19.0) | 6 (30.0) | 6 (75.0) | 1 (25.0) | 0 | 0 | 35 (19.7) | | PB | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
|
